GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
To Evaluate Oral Health and Quality of Life Associated With Use of a Denture Adhesive
- First Posted Date
- 2019-01-17
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 119
- Registration Number
- NCT03807700
- Locations
- 🇨🇦
GSK Investigational Site, Mississauga, Canada
To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function
- Conditions
- Interventions
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 158
- Registration Number
- NCT03804710
- Locations
- 🇩🇪
GSK Investigational Site, Schenefeld, Schleswig-Holstein, Germany
A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine
- Conditions
- Interventions
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 630
- Registration Number
- NCT03803202
- Locations
- 🇺🇸
Benchmark Research, San Angelo, Texas, United States
🇺🇸Artemis Institute, San Marcos, California, United States
🇺🇸Research Centers of America, Hollywood, Florida, United States
Managed Access Program for Combination Treatment With Belantamab Mafodotin in Multiple Myeloma
- Conditions
- First Posted Date
- 2018-12-04
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT03763370
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)
- Conditions
- Interventions
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 176
- Registration Number
- NCT03739710
- Locations
- 🇸🇪
GSK Investigational Site, Uppsala, Sweden
Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
- First Posted Date
- 2018-10-17
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 34
- Registration Number
- NCT03709706
- Locations
- 🇬🇧
GSK Investigational Site, Manchester, United Kingdom
A Study to Investigate Food Occlusion Efficacy of a Denture Adhesive in Denture Wearers
- Conditions
- Interventions
- First Posted Date
- 2018-10-17
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 49
- Registration Number
- NCT03709810
- Locations
- 🇺🇸
GSK Investigational Site, Fort Wayne, Indiana, United States
A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma
- Conditions
- Interventions
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT03707678
Pooled Analysis of Clinical Data From Six GSK Studies to Investigate the Efficacy of a Dentifrice Containing 67% Weight by Weight (w/w) Sodium Bicarbonate on Gingivitis and Plaque Accumulation
- Conditions
- Interventions
- First Posted Date
- 2018-10-11
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1601
- Registration Number
- NCT03703245
- Locations
- 🇬🇧
GSK Investigational Site, Weybridge, Surrey, United Kingdom
Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma
- Conditions
- First Posted Date
- 2018-10-10
- Last Posted Date
- 2020-04-13
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT03702036